<SEC-DOCUMENT>0001104659-22-020368-index.html : 20220211
<SEC-HEADER>0001104659-22-020368.hdr.sgml : 20220211
<ACCEPTANCE-DATETIME>20220211151015
ACCESSION NUMBER:		0001104659-22-020368
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220211
DATE AS OF CHANGE:		20220211
GROUP MEMBERS:		FORESITE CAPITAL MANAGEMENT IV, LLC
GROUP MEMBERS:		JAMES TANANBAUM

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lyell Immunopharma, Inc.
		CENTRAL INDEX KEY:			0001806952
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				833006753
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93402
		FILM NUMBER:		22619981

	BUSINESS ADDRESS:	
		STREET 1:		201 HASKINS WAY
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650 695-0677

	MAIL ADDRESS:	
		STREET 1:		201 HASKINS WAY
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Foresite Capital Fund IV, L.P.
		CENTRAL INDEX KEY:			0001704131
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		600 MONTGOMERY STREET, SUITE 4500
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		415-877-4887

	MAIL ADDRESS:	
		STREET 1:		600 MONTGOMERY STREET, SUITE 4500
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>tm225964d1_sc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: tm225964d1_sc13g.htm

</DOCUMENT>
</SEC-DOCUMENT>